ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
SPDR S&P Biotech ETF
124.78
-1.9600
-1.55%
盘后:
124.72
-0.0600
-0.05%
19:53 EST
成交量:
1,335.50万
成交额:
16.64亿
市值:
78.80亿
市盈率:
6.84
高:
125.60
开:
124.82
低:
122.94
收:
126.74
52周最高:
132.09
52周最低:
66.66
股本:
6,315.00万
流通股本:
6,315.00万
量比:
1.72
换手率:
21.15%
股息:
0.44
股息率:
0.35%
每股收益(TTM):
18.23
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
美国医疗保险优势计划增长再度放缓
环球市场播报
·
02/19
和谐健康保险泰州中支被罚69万,副总被罚15万
蓝鲸财经
·
02/14
创业慧康新注册《创业医疗健康数据汇聚系统软件V6》等2个项目的软件著作权
中金财经
·
02/14
AMN医疗保健服务公司盘中异动 临近收盘大幅下挫5.03%报19.34美元
市场透视
·
02/12
Humana公布季度亏损扩大,预计2026年盈利将下降
环球市场播报
·
02/11
Healthcare Services第四季度EPS为0.44美元 高于预期
格隆汇
·
02/11
和谐健康保险泰安中支被罚16万,涉编制虚假资料
蓝鲸财经
·
02/11
医疗保健板块动态:市场快讯解读
投资观察
·
02/11
AMN医疗保健服务公司盘中异动 下午盘股价大涨5.27%
市场透视
·
02/11
贝莱德大中华区陆文杰:中国经济2026将保持强劲增长,电力和医疗健康确定性更好
华尔街见闻
·
02/09
【投融资动态】安济盛生物D轮融资,融资额1.3亿美元,投资方为Frazier Life Sciences、Venrock Healthcare Capital Partners等
中金财经
·
02/08
2026年度南昌市灵活就业人员缴纳医保指南出炉
南昌发布
·
02/07
一批制造公众用药焦虑,引导购买高端医疗保险的账号被依法处置
市场资讯
·
02/06
【券商聚焦】中信证券:商保有望成为医疗健康产业支付端的核心增量
金吾财讯
·
02/06
医疗保健板块动态:市场焦点解读
投资观察
·
02/06
Viemed Healthcare, Inc.盘中异动 股价大涨5.19%报8.52美元
市场透视
·
02/06
Healthcare Triangle, Inc.盘中异动跌6.40% 换手率达47.93%
市场透视
·
02/05
瑞银——美国医疗保健服务行业周度观察(附下载)
外资精华观点
·
02/05
复星医药:公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务
证券日报
·
02/04
一线|脑机接口商业化转向:企业正加速从消费场景转向医疗健康领域
蓝鲸财经
·
02/04
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/XBI/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":124.78,"timestamp":1771621200000,"preClose":126.74,"halted":0,"volume":13355039,"hourTrading":{"tag":"盘后","latestPrice":124.72,"preClose":124.78,"latestTime":"19:53 EST","volume":2409541,"amount":300614794.999499,"timestamp":1771635227884,"change":-0.06,"changeRate":-0.000481,"amplitude":0.003927},"delay":0,"changeRate":-0.015464730945242179,"floatShares":63150000,"shares":63150000,"eps":18.23,"marketStatus":"休市中","change":-1.96,"latestTime":"02-20 16:00:00 EST","open":124.82,"high":125.6,"low":122.94,"amount":1663949181.94104,"amplitude":0.020988,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":126.74,"sharesOutstanding":63150000,"nav":126.732455,"aum":8003154505.4,"dividendRate":0.003545,"bidAskSpread":0.000179,"preHourTrading":{"tag":"盘前","latestPrice":125.06,"preClose":126.74,"latestTime":"09:29 EST","volume":16404,"amount":2049493.45056,"timestamp":1771597799999,"change":-1.68,"changeRate":-0.013255,"amplitude":0.009411},"postHourTrading":{"tag":"盘后","latestPrice":124.72,"preClose":124.78,"latestTime":"19:53 EST","volume":2409541,"amount":300614794.999499,"timestamp":1771635227884,"change":-0.06,"changeRate":-0.000481,"amplitude":0.003927},"volumeRatio":1.7184091468222418,"optionData":{"bulkOrders":[{"symbol":"XBI","call":true,"expireDate":1773979200000,"strike":"125.0","timestamp":1771621186384,"price":4.4,"volume":10000,"amount":4400000,"type":"+"},{"symbol":"XBI","call":true,"expireDate":1773979200000,"strike":"135.0","timestamp":1771621186320,"price":0.93,"volume":10000,"amount":930000,"type":"-"}]},"impliedVol":0.3238,"impliedVolPercentile":0.6853},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":63150000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.7184091468222418,"shares":63150000,"dividePrice":0.4423,"high":125.6,"amplitude":0.020988,"preClose":126.74,"low":122.94,"week52Low":66.66,"pbRate":"--","week52High":132.09,"institutionHeld":0.8511,"latestPrice":124.78,"eps":18.23,"divideRate":0.003545,"volume":13355039,"delay":0,"ttmEps":18.23,"open":124.82,"prevYearClose":121.93,"prevWeekClose":122.86,"prevMonthClose":124.75,"prevQuarterClose":121.93,"fiveDayClose":123.18,"twentyDayClose":131.57,"sixtyDayClose":116.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.057833,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612688286","title":"美国医疗保险优势计划增长再度放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=2612688286","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612688286?lang=zh_cn&edition=fundamental","pubTime":"2026-02-19 23:20","pubTimestamp":1771514400,"startTime":"0","endTime":"0","summary":"美国医疗保险优势计划参保人数同比增长放缓至约3%,在定价和医疗成本压力下,休曼纳(Humana)增加了会员,而联合健康集团和CVS Health旗下的安泰则流失了参保人。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-19/doc-inhnkpth0848747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","LABU","XBI","BK4585","BK4588","BK4581"],"gpt_icon":0},{"id":"2611101921","title":"和谐健康保险泰州中支被罚69万,副总被罚15万","url":"https://stock-news.laohu8.com/highlight/detail?id=2611101921","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611101921?lang=zh_cn&edition=fundamental","pubTime":"2026-02-14 23:03","pubTimestamp":1771081408,"startTime":"0","endTime":"0","summary":"蓝鲸新闻2月14日讯,近日,国家金融监督管理总局泰州监管分局发布了罚单,剑指和谐健康保险股份有限公司泰州中心支公司及其相关责任人。罚单显示,和谐健康保险股份有限公司泰州中心支公司的主要违法违规事实(案由)为:业务数据不真实、承诺给予或给予客户保险合同约定以外利益、财务数据不真实。针对上述违法违规行为,国家金融监督管理总局泰州监管分局对其罚款69万元;对和谐健康保险股份有限公司泰州中心支公司副总经理王擎警告并处罚款15万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1771068889721567457","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["XBI","XLV","BK4588","BK4581","BK4585","LABU"],"gpt_icon":0},{"id":"2611192456","title":"创业慧康新注册《创业医疗健康数据汇聚系统软件V6》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2611192456","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611192456?lang=zh_cn&edition=fundamental","pubTime":"2026-02-14 09:34","pubTimestamp":1771032850,"startTime":"0","endTime":"0","summary":"证券之星消息,近日创业慧康新注册了2个项目的软件著作权,包括《创业医疗健康数据汇聚系统软件V6》、《创业医疗健康数据模型管理系统软件V6》等。今年以来创业慧康新注册软件著作权6个,较去年同期增加了20%。通过天眼查大数据分析,创业慧康科技股份有限公司共对外投资了61家企业,参与招投标项目8200次;财产线索方面有商标信息65条,专利信息123条,著作权信息780条;此外企业还拥有行政许可74个。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260214/32018863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0114","159760","XBI","VGT","161022","BK4588","LU0405327148.USD","300451","BK4585","BK0146","LABU","BK4581","XLV","LU0405327494.USD","BK0231"],"gpt_icon":0},{"id":"2610946007","title":"AMN医疗保健服务公司盘中异动 临近收盘大幅下挫5.03%报19.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610946007?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 04:39","pubTimestamp":1770842399,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日04时39分,AMN医疗保健服务公司股票出现波动,股价快速跳水5.03%。截至发稿,该股报19.34美元/股,成交量66.875万股,换手率1.74%,振幅5.88%。AMN医疗保健服务公司股票所在的医疗设施行业中,整体涨幅为5.58%。AMN医疗保健服务公司公司简介:AMN Healthcare Services Inc 在美国提供医疗保健劳动力解决方案和人员配备服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021204400097a5d710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021204400097a5d710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XLV","AMN","XBI","BK4588","BK4196","BK4581","LABU","BK4585"],"gpt_icon":0},{"id":"2610955288","title":"Humana公布季度亏损扩大,预计2026年盈利将下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955288","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955288?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 22:29","pubTimestamp":1770820140,"startTime":"0","endTime":"0","summary":"Humana公司公布第四季度亏损扩大,原因是医疗成本持续上升,并表示由于其联邦医疗保险计划的质量评级下降,预计 2026 年盈利将大幅下滑。 该公司报告亏损 10.1 亿美元,合每股亏损 6.61 美元;去年同期亏损 8.62 亿美元,合每股亏损 5.76 美元。 Humana预计,2026 年个人联邦医疗保险优选计划会员数量将增长约 25%,“这得益于公司以客户为导向的福利策略带来的新增销售与留存率提升,以及客户服务模式的优化”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-11/doc-inhmnhqz7462659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4588","BK4585","XLV","BK4581","LABU"],"gpt_icon":0},{"id":"2610934545","title":"Healthcare Services第四季度EPS为0.44美元 高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2610934545","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610934545?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 20:01","pubTimestamp":1770811298,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","LABU","XLV","BK4588","BK4581","XBI","HCAR"],"gpt_icon":0},{"id":"2610933683","title":"和谐健康保险泰安中支被罚16万,涉编制虚假资料","url":"https://stock-news.laohu8.com/highlight/detail?id=2610933683","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610933683?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 17:54","pubTimestamp":1770803676,"startTime":"0","endTime":"0","summary":"蓝鲸新闻2月11日讯,近日,国家金融监督管理总局泰安监管分局发布了罚单,剑指和谐健康保险股份有限公司泰安中心支公司及其时任经理陈传美。罚单显示,和谐健康保险股份有限公司泰安中心支公司的主要违法违规事实为:编制虚假资料。针对这一行为,国家金融监督管理总局泰安监管分局对其罚款16万元;对时任和谐健康保险股份有限公司泰安中心支公司营业部经理陈传美,警告并处以1.5万元罚款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770801258420902225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4585","BK4581","XLV","XBI","BK4588","LABU"],"gpt_icon":0},{"id":"1186140440","title":"医疗保健板块动态:市场快讯解读","url":"https://stock-news.laohu8.com/highlight/detail?id=1186140440","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186140440?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 17:23","pubTimestamp":1770801827,"startTime":"0","endTime":"0","summary":"0241 GMT——尽管哈塔勒加集团在第三财季业绩超预期,但其销售增长动能仍显不足,联昌国际证券分析师陈成荣在研究报告中指出。他表示,手套供应过剩局面预计将至少持续至2027年,供需才能重新平衡。陈成荣将哈塔勒加2026至2028财年的核心净利润预测分别上调126%、70%和41%,主要基于成本假设的下调。联昌国际将其目标价从1.18林吉特下调至1.00林吉特,维持持有评级。该股当前上涨2.2%,报0.94林吉特。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","XLV","BK4588","LABU","BK4585"],"gpt_icon":0},{"id":"2610937278","title":"AMN医疗保健服务公司盘中异动 下午盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610937278?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 02:35","pubTimestamp":1770748555,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时35分,AMN医疗保健服务公司股票出现波动,股价大幅拉升5.27%。AMN医疗保健服务公司股票所在的医疗设施行业中,整体涨幅为0.31%。其相关个股中,Park Dental Partners, Inc.、Docgo Inc.、AMN医疗保健服务公司涨幅较大,Newgenivf Group Limited、Agilon Health, Inc.、P3 Health Partners Inc.较为活跃,换手率分别为19.38%、2.69%、2.62%,振幅较大的相关个股有The Oncology Institute Inc C/Wts 、Agilon Health, Inc.、P3 Health Partners Inc.,振幅分别为22.92%、16.71%、15.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102355597a5aed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102355597a5aed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMN","BK4585","BK4196","XLV","BK4581","XBI","BK4588","LABU"],"gpt_icon":0},{"id":"2610007633","title":"贝莱德大中华区陆文杰:中国经济2026将保持强劲增长,电力和医疗健康确定性更好","url":"https://stock-news.laohu8.com/highlight/detail?id=2610007633","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610007633?lang=zh_cn&edition=fundamental","pubTime":"2026-02-09 16:07","pubTimestamp":1770624436,"startTime":"0","endTime":"0","summary":"AI将迎来新一轮历史性建设浪潮","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3765312","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3765312","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"贝莱德大中华区陆文杰:中国经济2026将保持强劲增长,电力和医疗健康确定性更好","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4533","LU0157215616.USD","MCHI","CQQQ","IE00BGHQF631.EUR","DRAG","IE00B64PRP62.GBP","LU1599440770.SGD","LU1280957306.USD","LU1988902786.USD","LU2592432038.USD","BK4588","BK4567","LU0648001328.SGD","BK4135","LU0963586101.USD","IE00BGHQF748.EUR","BK4535","LU0208291251.USD","HXC","LU1074936037.SGD","CWEB","LU2430703251.USD","LU2264538146.SGD","BK4581","LU2505996681.GBP","LU0980610538.SGD","LU0070302665.USD","BK4614","BK4534","LU0640476718.USD","LU0742537680.HKD","LU1064131342.USD","LU1481011911.USD","LU1291159041.SGD","LU2430703178.SGD","LABU","LU1670627923.USD","LU1670628061.USD","LU1201861249.SGD","IE00B3QW5Z07.USD","BLK","LU1481011671.HKD","IE00B42XCP33.USD","LU2430703095.HKD","LU0772969993.USD","LU1509826696.USD","LU1989771016.USD","IE00BVYPNW00.USD","LU0320765489.SGD","XBI","ASHS","LU0130102774.USD","IE00BVYPNV92.GBP","LU2505996509.AUD","BK4585","LU0731783048.USD","ASHR","LU0731783394.SGD","LU1366333091.USD","IE00BDGV0183.EUR","IE00B3PB1722.GBP","KWEB"],"gpt_icon":0},{"id":"2609504579","title":"【投融资动态】安济盛生物D轮融资,融资额1.3亿美元,投资方为Frazier Life Sciences、Venrock Healthcare Capital Partners等","url":"https://stock-news.laohu8.com/highlight/detail?id=2609504579","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609504579?lang=zh_cn&edition=fundamental","pubTime":"2026-02-08 20:03","pubTimestamp":1770552185,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于2月4日公布的信息整理,安济盛生物医药技术(广州)有限公司D轮融资,融资额1.3亿美元,参与投资的机构包括Frazier Life Sciences,Venrock Healthcare Capital Partners,Ascenta Capital,BlackRock Innovation Capital,BVF,Logos Capital,RA Capital Management,威灵顿,Bain Capital Life Sciences,Elikon Venture,Janus Henderson,三正健康,高瓴资本,君联资本,晨兴创投,奥博资本,泰福资本,涌铧投资。安济盛生物医药技术(广州)有限公司成立于2018年6月,地处广州科学城,是一家专注于骨骼肌肉关节等疾病新药研发的跨国研发企业。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202602/08/20260208385613.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202602/08/20260208385613.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260208/32006199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["XBI","HCCCU","BK4588","LABU","BK4581","BK4585","XLV"],"gpt_icon":0},{"id":"2609254915","title":"2026年度南昌市灵活就业人员缴纳医保指南出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2609254915","media":"南昌发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609254915?lang=zh_cn&edition=fundamental","pubTime":"2026-02-07 14:30","pubTimestamp":1770445800,"startTime":"0","endTime":"0","summary":"灵活就业人员自愿参加职工医保的,应当按年一次性缴纳全年费用,不允许按月缴费,待遇享受按有关规定执行。职工医保停保后转为以灵活就业人员身份参保的,可从停保次月一次性缴费至当年的12月31日。当年已参加居民医保并缴费的,不得中途再以灵活就业人员身份参加当年职工医保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-02-07/doc-inhkykzi4247953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","XLV","BK4588","BK4581","XBI","BK4585"],"gpt_icon":0},{"id":"2609459639","title":"一批制造公众用药焦虑,引导购买高端医疗保险的账号被依法处置","url":"https://stock-news.laohu8.com/highlight/detail?id=2609459639","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609459639?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 20:23","pubTimestamp":1770380580,"startTime":"0","endTime":"0","summary":"来源:北京商报\n 2月6日,北京商报记者了解到,近期,中央网信办会同国家医保局深入整治涉医药集中带量采购的网上虚假不实信息,依法依约处置一批污名集采、制造焦虑、误导公众的账号。根据通报的典型案例,微博账号“成都XXX”,抖音账号“琼波XX”“亮晶晶的XX”等,歪曲国家政策,编造“进口药集体退出中国”等不实信息,煽动网民对原研药与仿制药的对立情绪,其中部分账号旨在制造公众用药焦虑,引导公众购买相关保健品、高端医疗保险,或诱导公众到特定的互联网平台购药。涉及的账号已被依法依约采取处置措施。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:曹睿潼","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-06/doc-inhkwssf2096736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4581","XLV","BK4588","LABU","BK4585"],"gpt_icon":0},{"id":"2609536060","title":"【券商聚焦】中信证券:商保有望成为医疗健康产业支付端的核心增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2609536060","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609536060?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 08:31","pubTimestamp":1770337883,"startTime":"0","endTime":"0","summary":"下一阶段,该机构认为商保综合服务提供商有望解决保司端人才、数据制约,打开创新药械企业创新价值兑现面临的结构性瓶颈,进一步助推商业健康险行业边际加速发展。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974659","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","LU1064130708.USD","LU1655091616.SGD","BK4585","LABU","BK0012","LU1328615791.USD","BK0028","BK0183","LU1997244956.HKD","BK1564","LU1997245177.USD","BK0276","LU1997245094.SGD","BK1521","LU2495084118.USD","BK0196","LU0405327494.USD","600030","LU1255011170.USD","LU1794554557.SGD","06030","LU2148510915.USD","LU1064131003.USD","LU0405327148.USD","LU2289578879.USD","XLV","XBI","BK4588","LU1720050803.USD","BK4581","BK1147","159760","BK1516"],"gpt_icon":0},{"id":"1125439079","title":"医疗保健板块动态:市场焦点解读","url":"https://stock-news.laohu8.com/highlight/detail?id=1125439079","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125439079?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 05:52","pubTimestamp":1770328365,"startTime":"0","endTime":"0","summary":"最新一期医疗保健板块市场动态分析。Neuren公司表示,其合作伙伴Acadia Pharmaceuticals近期收到欧洲药品管理局关键委员会的通报,trofinetide的上市许可申请未获支持票。杰富瑞在报告中称:\"基于此消息并保持审慎态度,我们现预计trofinetide在欧盟销售的版权收益将于2026财年第四季度初实现。得益于影像类产品的强劲需求,这家德国医疗企业的市场份额持续扩大。分析师补充道,该公司始终是板块重点推荐标的。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4585","XLV","BK4581","LABU"],"gpt_icon":0},{"id":"2609651523","title":"Viemed Healthcare, Inc.盘中异动 股价大涨5.19%报8.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609651523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609651523?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 04:10","pubTimestamp":1770322215,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日04时10分,Viemed Healthcare, Inc.股票出现异动,股价急速拉升5.19%。Viemed Healthcare, Inc.股票所在的医疗器械行业中,整体涨幅为0.15%。其相关个股中,Trisalus Life Sciences Inc C/Wts 10/08/28 、Tenon Medical Inc C/Wts 16/06/2028 、Nexalin Technology, Inc.涨幅较大,Envue Medical, Inc.、Nexalin Technology, Inc.、Intelligent Bio Solutions Inc.较为活跃,换手率分别为221.64%、31.32%、18.00%,振幅较大的相关个股有Tela Bio, Inc.、Envue Medical, Inc.、Nuwellis, Inc.,振幅分别为60.01%、19.17%、18.27%。Viemed Healthcare, Inc.公司简介:Viemed Healthcare Inc 是一家为呼吸系统疾病、汲氧问题、睡眠呼吸暂停和 PAP 治疗患者提供医疗设备和家庭治疗的供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020604101595400892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020604101595400892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","XBI","BK4581","VMD","XLV","BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2609588416","title":"Healthcare Triangle, Inc.盘中异动跌6.40% 换手率达47.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609588416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609588416?lang=zh_cn&edition=fundamental","pubTime":"2026-02-05 23:34","pubTimestamp":1770305648,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日23时34分,Healthcare Triangle, Inc.股票出现波动,股价急速跳水6.40%。Healthcare Triangle, Inc.股票所在的健康信息服务行业中,整体跌幅为1.74%。Healthcare Triangle, Inc.公司简介:Healthcare Triangle Inc 是一家专注于推动行业变革解决方案的医疗信息技术公司,主要关注云服务、数据科学以及医疗和生命科学行业的专业与托管服务领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020523340897a510bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020523340897a510bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XLV","HCTI","XBI","BK4588","BK4581","LABU","BK4167","BK4585"],"gpt_icon":0},{"id":"2609737157","title":"瑞银——美国医疗保健服务行业周度观察(附下载)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609737157","media":"外资精华观点","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609737157?lang=zh_cn&edition=fundamental","pubTime":"2026-02-05 15:42","pubTimestamp":1770277357,"startTime":"0","endTime":"0","summary":"免费体验“高时效”国际投行研报“T+0至T+1”“原研报”可至底部下载瑞银——美国医疗保健服务行业周度观察:医疗人员配置与急性期后护理板块表现突出,美国医疗支出增长,管理式医疗CEO将出席听证会精华翻译 板块表现分化:截至1月16日当周,医疗保健服务类股上涨0.6%,跑赢标普500指数及 broader医疗保健指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161612a47f4a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161612a47f4a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0128526141.USD","BK4137","BK4581","XBI","XLV","BK4585","LU0029874061.USD","LABU","HCSG","BK4588"],"gpt_icon":0},{"id":"2608362077","title":"复星医药:公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362077","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608362077?lang=zh_cn&edition=fundamental","pubTime":"2026-02-04 21:37","pubTimestamp":1770212245,"startTime":"0","endTime":"0","summary":"证券日报网讯2月4日,复星医药在互动平台回答投资者提问时表示,公司自1994年创立于上海,是一家植根中国、创新驱动的全球化医药健康产业集团。目前,公司直接运营的业务覆盖制药、医疗器械及医学诊断、医疗健康服务;其中,制药是公司的核心主营业务,也是公司品牌建设的重要承载。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602043641720167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4581","BK1515","159883","BK0060","BK0188","BK0012","09997","600196","BK1100","BK4585","01477","BK1222","BK0187","BK0096","BK1574","BK0183","BK0028","159760","BK1583","BK1593","BK4588","BK0239","BK1191","BK0196","LABU","09996","XLV","BK0175","02196"],"gpt_icon":0},{"id":"2608334357","title":"一线|脑机接口商业化转向:企业正加速从消费场景转向医疗健康领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2608334357","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608334357?lang=zh_cn&edition=fundamental","pubTime":"2026-02-04 18:08","pubTimestamp":1770199680,"startTime":"0","endTime":"0","summary":"随着研发与产业化的推进,脑机接口的商业化重心正明显向医疗健康领域集中。脑机接口设备日趋便携化、小型化,并在国内完善产业链的支撑下走向大规模量产。脑机接口领域在蓬勃发展的表象之下,亦潜藏着根本性的战略分歧。脑机接口行业从业人员李飞告诉蓝鲸科技记者。当脑机接口决定认真“治病”近年来,脑机接口企业正加速从消费场景转向医疗健康领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770193931196031365","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","XLV","BK4585","LABU","BK4581","159760","XBI"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":142,"code":"91000000","status":"200"}]}}